Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple sclerosis”
Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT04823000. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
ClinicalTrials.gov study NCT01271699. IPD Sharing: UNDECIDED. Countries: 0. Publications: 11.
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
ClinicalTrials.gov study NCT03408093. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
ClinicalTrials.gov study NCT04754542. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT02064816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Administration of Fingolimod in Greek Patients With Multiple Sclerosis.
ClinicalTrials.gov study NCT06949956. IPD Sharing: NO. Countries: 0. Publications: 3.
Prescription Drug Safety and Effectiveness in Multiple Sclerosis
ClinicalTrials.gov study NCT04472975. IPD Sharing: NO. Countries: 0. Publications: 1.
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04480853. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
ClinicalTrials.gov study NCT06846281. IPD Sharing: YES. Countries: 16. Publications: 0.
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
ClinicalTrials.gov study NCT00418145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis
ClinicalTrials.gov study NCT03219073. IPD Sharing: NO. Countries: 1. Publications: 0.
Dalfampridine for Imbalance in Multiple Sclerosis
ClinicalTrials.gov study NCT01444300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Investigate the Effect of Aerobic Exercise on Neurophysiological Values and Functionality in Individuals With Multiple Sclerosis.
ClinicalTrials.gov study NCT04121637. IPD Sharing: NO. Countries: 0. Publications: 22.
Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04767698. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT01199861. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Care in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT07011914. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis
ClinicalTrials.gov study NCT01214317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
ClinicalTrials.gov study NCT03172741. IPD Sharing: NO. Countries: 0. Publications: 3.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]
ClinicalTrials.gov study NCT01134627. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atorvastatin in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00616187. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.